150 related articles for article (PubMed ID: 38706915)
1. GPNMB Expression Associates with Inferior Prognosis in Patients with Small Cell Lung Cancer.
Liu Q; Zhang J; Mao S; Zhang D; Dong Y; Hu P; Ren S
J Cancer; 2024; 15(10):2960-2970. PubMed ID: 38706915
[No Abstract] [Full Text] [Related]
2. CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer.
Liu Q; Qiao M; Lohinai Z; Mao S; Pan Y; Wang Y; Yang S; Zhou F; Jiang T; Yi X; Ren S; Zhou C; Hirsch FR
Lung Cancer; 2021 Dec; 162():194-202. PubMed ID: 34823893
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer.
Li YN; Zhang L; Li XL; Cui DJ; Zheng HD; Yang SY; Yang WL
APMIS; 2014 Feb; 122(2):140-6. PubMed ID: 23656629
[TBL] [Abstract][Full Text] [Related]
4. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.
Geng N; Ding CM; Liu ZK; Song S; Hu WX
Int J Clin Oncol; 2021 Apr; 26(4):670-683. PubMed ID: 33392882
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer.
Zhang X; Ren H; Tian J; Yang C; Luo H
Heliyon; 2024 Jan; 10(1):e23830. PubMed ID: 38192754
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy.
Qin C; Liu Z; Yuan Y; Zhang X; Li H; Zhang C; Xu T; Wang X
Mol Med Rep; 2014 Mar; 9(3):851-6. PubMed ID: 24425288
[TBL] [Abstract][Full Text] [Related]
7. Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.
Yang W; Wang W; Li Z; Wu J; Xu X; Chen C; Ye X
J Cancer; 2023; 14(9):1541-1552. PubMed ID: 37325062
[No Abstract] [Full Text] [Related]
8. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.
Huang YH; Chu PY; Chen JL; Huang CT; Huang CC; Tsai YF; Wang YL; Lien PJ; Tseng LM; Liu CY
Sci Rep; 2021 Jun; 11(1):12171. PubMed ID: 34108545
[TBL] [Abstract][Full Text] [Related]
10. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes.
Wang X; Guo Y; Liu L; Wei J; Zhang J; Xie T; Dong J; Li J; Xing P; Yang L
Lung Cancer; 2021 Oct; 160():166-174. PubMed ID: 34364705
[TBL] [Abstract][Full Text] [Related]
11. GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma.
Zhai JP; Liu ZH; Wang HD; Huang GL; Man LB
Oncol Lett; 2022 Jan; 23(1):36. PubMed ID: 34966452
[TBL] [Abstract][Full Text] [Related]
12. Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer.
Sun B; Hou Q; Liang Y; Xue S; Yao N; Wei L; Cao X; Li H; Si H; Cao J
BMC Cancer; 2022 Nov; 22(1):1233. PubMed ID: 36447193
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC.
Zhang C; Shang X; Sun J; Li Z; Lin J; Zhao C; Wang H
Int J Gen Med; 2021; 14():6899-6906. PubMed ID: 34703294
[TBL] [Abstract][Full Text] [Related]
14. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
15. The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis.
Ning J; Ge T; Zhu S; Han Y; Ruan S; Ma Y; Liu R
Front Oncol; 2022; 12():958187. PubMed ID: 36249007
[TBL] [Abstract][Full Text] [Related]
16. Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis.
Zhou N; Yang L; Zhang B; Zhu S; Huo H; He J; Zu L; Song Z; Xu S
Cancer Med; 2023 Apr; 12(7):7923-7931. PubMed ID: 36567517
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
18. Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer.
Zhao C; Tong L; Liu B; Qi F; Zhang Z; Guo Y; Liu Y; Wang Y; Zhang L; Lu B; Li B; Zhang T
BMC Cancer; 2023 Oct; 23(1):973. PubMed ID: 37828456
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study.
Xie J; Xu K; Cai Z; Chen M; Jiang Y; Ye J; Lin X; Lv T; Zhan P
Transl Lung Cancer Res; 2024 Mar; 13(3):526-539. PubMed ID: 38601454
[TBL] [Abstract][Full Text] [Related]
20. GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.
Kawasaki Y; Suzuki H; Suzuki S; Yamada T; Suzuki M; Ito A; Hatakeyama H; Miura M; Omori Y
Pathol Oncol Res; 2022; 28():1610450. PubMed ID: 36061142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
